Stock MEDIGENE AG
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Analyst Reco. MediGene AG Xetra

Equities

DE0005020903

End-of-day quote Xetra
Other stock markets
- EUR - Intraday chart for MediGene AG
Jul. 03 Medigene AG Expands Patent Portfolio with the Patent Grant for its NY-ESO-1/LAGE 1a Targeted T Cell Receptor in China CI
Jun. 27 Medigene Presents Efficient 6-Day TCR-T Therapy Production Process with High Stemness CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
MEDIGENE AG : Baader Bank reaffirms its Neutral rating
ZD
Berenberg Goldman Sachs German Corporate Conference
FA
MEDIGENE AG : Baader Bank revises his opinion and turns to Neutral
ZD
Berenberg and Goldman Sachs German Corporate Conference
FA
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MDG1 Stock
  4. Stock
  5. News MediGene AG
  6. Analyst Reco.